Conference Coverage

Overtreatment common in high-risk diabetes patients

Publish date: July 22, 2013

 

AT THE ADA ANNUAL SCIENTIFIC SESSIONS

The Department of Veterans Affairs supported the study. Dr. Pogach reported having no financial conflicts of interest.

bjancin@frontlinemedcom.com

Pages

Recommended Reading

Insulin boosted memory in patients with high-risk Alzheimer's allele
MDedge Endocrinology
Would patients open wallets for fewer diabetes drug doses?
MDedge Endocrinology
Two meals per day better than six in T2DM
MDedge Endocrinology
Children of diabetic mothers at greater risk of overweight as young adults
MDedge Endocrinology
Pilot study: Vitamin D promising for diabetic pain
MDedge Endocrinology
Octogenarians hard hit by insulin adverse events
MDedge Endocrinology
Aging-related functional decline boosts diabetes risk
MDedge Endocrinology
Add-on dapagliflozin achieves combined weight/HbA1c reduction more often than glipizide
MDedge Endocrinology
Novel insulin/GLP-1 combo succeeds in phase III trial
MDedge Endocrinology
Osteoprotegerin ups risk of vascular events in type 1 diabetes
MDedge Endocrinology